Trial · NCT03320941
Results by group289
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 289
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Percentage Change From Baseline in Body Weight at Week 12 | LIK066 2.5mg qd | -1.86 | 95% Confidence Interval -2.59 to -0.67 | Percent Change | |
| Percentage Change From Baseline in Body Weight at Week 12 | LIK066 10mg qd | -2.84 | 95% Confidence Interval -3.79 to -2.16 | Percent Change | |
| Percentage Change From Baseline in Body Weight at Week 12 | LIK066 25 mg qd | -3.41 | 95% Confidence Interval -3.96 to -2.84 | Percent Change | |
| Percentage Change From Baseline in Body Weight at Week 12 | LIK066 50 mg qd | -3.80 | 95% Confidence Interval -4.48 to -3.17 | Percent Change | |
| Percentage Change From Baseline in Body Weight at Week 12 | Placebo | 0.11 | 95% Confidence Interval -0.90 to 0.97 | Percent Change | |
| Responder Rates According to Percentage Decrease in Body Weight From Baseline to Week 12 | LIK066 2.5mg qd | >= 3% | 15.8 | Percentage of Participants | |
| Responder Rates According to Percentage Decrease in Body Weight From Baseline to Week 12 | LIK066 10mg qd | >= 3% | 55.6 | Percentage of Participants | |
| Responder Rates According to Percentage Decrease in Body Weight From Baseline to Week 12 | LIK066 25 mg qd | >= 3% | 50.0 | Percentage of Participants | |
| Responder Rates According to Percentage Decrease in Body Weight From Baseline to Week 12 | LIK066 50 mg qd | >= 3% | 56.7 | Percentage of Participants | |
| Responder Rates According to Percentage Decrease in Body Weight From Baseline to Week 12 | Placebo | >= 3% | 7.1 | Percentage of Participants | |
| Responder Rates According to Percentage Decrease in Body Weight From Baseline to Week 12 | LIK066 2.5mg qd | >= 5% | 5.3 | Percentage of Participants | |
| Responder Rates According to Percentage Decrease in Body Weight From Baseline to Week 12 | LIK066 10mg qd | >= 5% | 27.8 | Percentage of Participants | |
| Responder Rates According to Percentage Decrease in Body Weight From Baseline to Week 12 | LIK066 25 mg qd | >= 5% | 17.9 | Percentage of Participants | |
| Responder Rates According to Percentage Decrease in Body Weight From Baseline to Week 12 | LIK066 50 mg qd | >= 5% | 26.7 | Percentage of Participants | |
| Responder Rates According to Percentage Decrease in Body Weight From Baseline to Week 12 | Placebo | >= 5% | 0.0 | Percentage of Participants | |
| Responder Rates According to Percentage Decrease in Body Weight From Baseline to Week 12 | LIK066 2.5mg qd | >= 10% | 0.0 | Percentage of Participants | |
| Responder Rates According to Percentage Decrease in Body Weight From Baseline to Week 12 | LIK066 10mg qd | >= 10% | 0.0 | Percentage of Participants | |
| Responder Rates According to Percentage Decrease in Body Weight From Baseline to Week 12 | LIK066 25 mg qd | >= 10% | 0.0 | Percentage of Participants | |
| Responder Rates According to Percentage Decrease in Body Weight From Baseline to Week 12 | LIK066 50 mg qd | >= 10% | 3.3 | Percentage of Participants | |
| Responder Rates According to Percentage Decrease in Body Weight From Baseline to Week 12 | Placebo | >= 10% | 0.0 | Percentage of Participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03320941/results